MAPK1 and benign prostatic hyperplasia: Comparative Analysis of miRNA Expression 106a‐5p and 375‐3p and Proteins ERK1/2, p38, β‐Catenin and E‐Cadherin in Prostate Cancer and Benign Prostatic Hyperplasia